4D Molecular Therapeutics FDMT SEC Filings

NASDAQ FDMT
$14.95 +0.25 (+1.70%)
As of: Sep 4, 2026 · 2:22 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document 4D Molecular Therapeutics, Inc. (FDMT) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index